Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE): An Open-label, Phase 2 Tria

NCT04907864 is registered in ClinicalTrials.gov with Kil Yeon Lee as lead sponsor.

NCT NCT04907864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04907864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE): An Open-label, Phase 2 Tria
Lead sponsor
Kil Yeon Lee
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2020
Completion date
June 30, 2022
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer, cachexia, colorectal cancer, gastric cancer, lung cancer, pancreatic cancer, precachexia